Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme
Challapalli, A Watkins, S Cogill, G Stewart, G Ellis, S Sykes, A Nobes, J Yip, K Barthakur, U Board, R
Challapalli, A
Watkins, S
Cogill, G
Stewart, G
Ellis, S
Sykes, A
Nobes, J
Yip, K
Barthakur, U
Board, R
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2022-03-17
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available.
Citation
Challapalli A, Watkins S, Cogill G, Stewart G, Ellis S, Sykes A, Nobes J, Yip K, Barthakur U, Board R, Gadve A, O'Toole L, Kent C, Mackenzie J, Papa S, Fusi A, Fife K. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e590-e592. doi: 10.1111/jdv.18082. Epub 2022 Mar 24.
Type
Correspondence